IL1B and neoplasm: IL-1β derived from TAMs suppresses the expression of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), an enzyme involved in prostaglandin degradation in PDAC cells, which results in tumor growth and poor prognosis for PDAC patients [145].